Physician profile
Eric Loesch
NPI 1497119366
$4,677.99
in general payments reported to CMS, 2019-2025
18 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what 76% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,203 · 2020: $116 · 2021: $237 · 2022: $353 · 2023: $322 · 2024: $447 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,769.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,295.47 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $848.48 | 2020-2025 | Dupixent |
| Abbvie INC. | $540.93 | 2023-2025 | |
| Janssen Biotech, INC. | $384.87 | 2024-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $228.36 | 2022 | |
| Genzyme Corporation | $211.81 | 2025 | |
| Lilly USA, LLC | $208.49 | 2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $175.91 | 2025 | Adbry, Anzupgo |
| Dermavant Sciences, INC. | $167.84 | 2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $126.42 | 2024-2025 | Zoryve |
| Janssen Scientific Affairs, LLC | $120.53 | 2021 | |
| Incyte Corporation | $112.08 | 2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.91 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.91 | 2025 | Cabtreo |
| Almirall LLC | $46.16 | 2025 | Klisyri |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $26.66 | 2025 | |
| Botanix Sb INC | $24.08 | 2025 | Sofdra |
| Galderma Laboratories, L.P. | $15.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Loesch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.